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Abstract  
Trichorhinophalangeal syndrome (TRPS) is the collective name of three rare congenital conditions characterised 
by craniofacial and skeletal abnormalities. The three known types of TRPS have different modalities of genetic 
transmission: namely, TRPS I and III are inherited as an autosomal dominant disease, while the cases of TRPS II 
are essentially sporadic.The diagnosis of the different types of TRPS is based on clinical and radiological findings, 
eventually integrated by genetic analysis, particularly useful in some cases with the non-classical clinical 
presentation. Alopecia and structural abnormalities of the nose and the hands should be considered as clinical 
hallmarks, whereas endocrine disorders, renal alterations, ureteral reflux, heart pathology and bone dysplasia 
have been documented, in the setting of a multisystem involvement. 
Introduction 
 
Trichorhinophalangeal syndrome (TRPS) is 
the collective name of three rare congenital conditions 
characterised by craniofacial and skeletal 
abnormalities. The three known types of TRPS have 
different modalities of genetic transmission: namely, 
TRPS I and III are inherited as an autosomal 
dominant disease, while the cases of TRPS II are 
essentially sporadic.The diagnosis of the different 
types of TRPS is based on clinical and radiological 
findings, eventually integrated by genetic analysis, 
particularly useful in some cases with the non-
classical clinical presentation. Alopecia and structural 
abnormalities of the nose and the hands should be 
considered as clinical hallmarks, whereas endocrine 
disorders, renal alterations, ureteral reflux, heart 
pathology and bone dysplasia have been 
documented, in the setting of a multisystem 
involvement. Pigmentation disorders have never been 
reported in TRPS patients. 
Herein is described a case of skin 
discoloration occurring in a boy affected by TRPS: it 
was only a fortuitous association? 
 
 
Case report 
 
A 16-year-old boy presented to our 
department with a complaint of an asymptomatic dirt-
like hyperpigmentation of the upper chest and 
abdomen, which had been present for about six 
months (Fig. 1). The condition became progressively 
more evident after holidays at the seaside, despite the 
routinary hygiene and the application of various 
emollients and oils.  
The patient was apparently health, although 
his hairs were referred as slowly growing and being, in 
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fact, thin and sparse. General physical examination 
was notable for pectus excavatum (Fig. 1), short and 
stubby hands with lateral deviations and deformations 
of the interphalangeal joints (Fig. 2). About these, he 
presented the report of a previous x-ray examination, 
showing cone-shaped epiphyses of the second to the 
fifth middle phalanges of both hands and bilateral 
brachymetacarpalia of the metacarpal IV. The short 
stature had also been strictly checked by his 
paediatrician, as well as the flat feet, the arched 
palate and the hypoplastic mandible.  
Biochemical and endocrinological 
investigations failed to demonstrate abnormal pituitary 
gland, related to the GH-IGF-1, hypothalamic-
pituitary-thyroid, -adrenal and -gonadal axis, and 
prolactin secretion.  
 
Figure 1: Physical examination showing skeletal abnormalities 
(pectus excavatum and left hand) and darkening of the skin of the 
lateral thorax 
 
On mother repeated interviewing, it emerges 
that other two members of the family (the father and 
the sister of the patient) presented similar skull 
features, having both triangular face, bulbous pear-
shaped nose, elongated philtrum, thin upper lip, 
horizontal groove on the chin and protruding ears. In 
particular, the sister, who was 20, was previous 
diagnosed with TRPS type I in 2008 through 
cytogenetic analysis. About the cutaneous concern, 
anamnesis was not significant for possible underlying 
diseases (diabetes, obesity or 
supplementations/medications assumption) and only 
the sister manifested similar hyperpigmentation of the 
umbilicus and axillae. He also denied local trauma, 
eczema or excessive use of cosmetics before. 
 
Figure 2: Particular of the hand: note the lateral deviations and 
deformations of the interphalangeal joints 
 
 
On physical examination, abnormal brown to 
dark discoloration of the lateral part of the thorax was 
apparent (Fig. 3). Dermoscopy of the lesions showed 
large polygonal plate-like brown scales arranged 
together giving an irregular mosaic pattern (Fig. 4). 
 
Figure 3: Brown to dark discoloration of the lateral part of the 
thorax. 
 
Tentative rubbing with 70% isopropyl alcohol 
lead to the partial removal of the hyperpigmented 
patch (Fig. 5), and the patient refused any further 
diagnostic procedure (e.g. punch biopsy). 
 
 
 
Discussion 
 
Trichorhinophalangeal syndrome type I is a 
malformation syndrome characterised by craniofacial 
and skeletal abnormalities [1]. Inherited in an 
autosomal dominant manner with high penetrance 
and variable expressivity, TRPS have sparse and 
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slow-growing hair, pear-shaped nose, elongated 
philtrum, thin upper lip, protruding ears and bone 
deformities, including cone-shaped epiphyses of the 
phalanges, hip malformations and short stature as 
typical clinical features [2]. 
 
Figure 4: Dermoscopy of the affected area (original magnification 
x60) 
 
Although there is a great variability in the 
clinical findings with considerable overlap, even 
among subjects of the same family,  three subgroups 
of TRPS can be distinguished: TRPS I, associated 
with alterations of chromosome 8 band q24.1, TRPS II 
caused by a  larger deletion, involving the TRPS 1 
and EXT 1 (hereditary multiple exostoses) genes 
(8q24.11-q24.13), and TRPS III which  results from 
missense mutations in exon 6 of TRPS1 [3]. 
Short stature is usual in TRPS type I [4]. 
Winged scapulae, multiple cartilaginous exostoses, 
redundant skin, and mental retardation are distinctive 
characteristics of TRPS type II, while severe 
brachydactyly, due to short metacarpals, and severe 
short stature are typical of TRPS type III [1, 5]. 
The diagnosis of the different types of TRPS 
is based on clinical and radiological findings, 
eventually integrated by genetic analysis, particularly 
useful in some cases with non-classical clinical 
presentation; other syndromes that include alopecia 
and structural abnormalities of the nose and the 
hands should be considered in differential diagnosis  
(Larsen’s syndrome, oral-facial-digital syndrome, 
Coffin-Siris syndrome, alopecia-onycho- dysplasia-
hypohidrosis-deafness syndrome, trichoonychodental 
dysplasia, Clouston’s syndrome, Ellis-van Creveld 
syndrome) [1, 2, 6, 7]. 
TRPS may be associated with endocrine 
disorders, renal  alterations, ureteral reflux, heart 
pathology and bone dysplasia: thus, a follow-up has to 
be set up in order to make an early diagnosis of a 
possible multisystemic involvement, a Perthes-like 
disease (dysplasia of the hip in >70% of the cases) 
[9], because of the frequent evolution in avascular 
necrosis of the femoral head (Legg-Perthes-Calvé 
disease) [9], or the appearance of exostoses because 
of a possible, although rare, sarcomatous  
degeneration [2]. Radvanyi et al. also showed that the 
TRPS1 gene is overexpressed in more than 90% of 
breast cancers [10]. 
Apart from the above mentioned cutaneous 
involvement, no other skin abnormalities have been 
reported in TRPS. In particular, no pigmentation 
disorders have been noted, according to with the 
updated literature. 
With regard to our case, dermatological 
findings should not strictly considered in the field of 
pigmentation disorders, since Terra Firma Forme 
Dermatosis (TFFD), or Duncan ‘dirty’ disease, implies  
Incomplete maturation of keratin squames, combined 
with retention of melanin and build-up and compaction 
of scales, sebum and dirt through inadequate 
cleansing [11]. In facts, TFFD is an idiopathic benign 
condition that may represent an exasperating skin 
defect, as it involves exposed areas in psychologically 
more fragile patient categories (mainly children and 
adolescents) with the features of ‘dirt’ and giving the 
picture of poor body hygiene [12]. Atopy seems to be 
a predisposing condition [13].
 
 
Figure 5: Partial removal of the pigmentation 
 
 
By excluding other dirty-appearing disorders, 
and using some ancillary tools (e.g. dermoscopy), the 
diagnosis is easy [13], thus avoiding inappropriate 
exams and unnecessary treatments [11, 12]. 
The occurrence of some cases presenting 
‘topographic’ disease (Unal E et al., unpublished data) 
and the anecdotal association with genetic diseases 
(Guarneri C et al., unpublished data) may suggest the 
possibility of a ‘syndromic’ phenotype, as in this case, 
and it is worthy of attention in future cases of these 
conditions.  
However, in clinical practice, TFFD is more 
frequent than the only 44 cases reported in literature 
lead to expect [14]. 
In conclusion, TRPS is a group of rare 
congenital conditions characterised by craniofacial 
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and skeletal abnormalities, Type I and III being more 
frequent and inherited as an autosomal dominant 
character. As the diagnosis is based on clinical and 
radiological findings, eventually integrated with 
genetic analysis, the role of a dermatologist is pivotal, 
through recognising the typical hallmarks and 
managing the further in-depth analyses. 
Specialist’s should also be aware of 
unexpected clinical signs, thus eventually expanding 
the phenotype of the disease and/or characterising 
new variants. 
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